Lineage Cell Therapeutics, Inc. (LCTX) vs Niagen Bioscience, Inc. (NAGE)

Lineage Cell Therapeutics, Inc. and Niagen Bioscience, Inc. are both Biotechnology companies. Lineage Cell Therapeutics, Inc. and Niagen Bioscience, Inc. are of similar size ($239.7M and $238.2M). Lineage Cell Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 15.2×. Lineage Cell Therapeutics, Inc. grew revenue faster over the last twelve months: 19.9% against 11.0%. Niagen Bioscience, Inc. has the higher net margin (12.4% vs −246.6%) and the higher return on invested capital (42.0% vs −186.8%). Across the 18 metrics below, Niagen Bioscience, Inc. leads on 14 and Lineage Cell Therapeutics, Inc. on 4.